These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16704680

  • 1. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.
    Yilmaz O, Eroglu A, Dag E, Karaoglanoglu N, Yilmaz A.
    Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680
    [Abstract] [Full Text] [Related]

  • 2. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 3. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
    Wang H, Wan YX, Zhang QK.
    Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
    [Abstract] [Full Text] [Related]

  • 4. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 5. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS, Tanriverdi F, Yilmaz MO, Ozcelik B, Unluhizarci K.
    Gynecol Endocrinol; 2008 Mar 15; 24(3):117-21. PubMed ID: 18335323
    [Abstract] [Full Text] [Related]

  • 6. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.
    Sohda M, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Kuwano H.
    Anticancer Res; 2004 Mar 15; 24(5A):3029-34. PubMed ID: 15517912
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST.
    Br J Cancer; 2000 Nov 15; 83(10):1344-50. PubMed ID: 11044360
    [Abstract] [Full Text] [Related]

  • 8. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE.
    Asian J Androl; 2008 Mar 15; 10(2):207-13. PubMed ID: 18097534
    [Abstract] [Full Text] [Related]

  • 9. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan 15; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 10. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May 01; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov 01; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun 01; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 14. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 Jun 01; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

  • 15. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B, Kural N, Colak O, Ak I, Akcar N.
    Clin Physiol Funct Imaging; 2008 Mar 01; 28(2):107-12. PubMed ID: 18093232
    [Abstract] [Full Text] [Related]

  • 16. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM.
    Clin Biochem; 2006 Jun 01; 39(6):623-9. PubMed ID: 16624274
    [Abstract] [Full Text] [Related]

  • 17. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 01; 15(6):1137-41. PubMed ID: 16775172
    [Abstract] [Full Text] [Related]

  • 18. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 19. Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.
    Rodriguez-Galindo C, Poquette CA, Daw NC, Tan M, Meyer WH, Cleveland JL.
    Med Pediatr Oncol; 2001 Jun 01; 36(6):605-11. PubMed ID: 11344491
    [Abstract] [Full Text] [Related]

  • 20. Serum insulin-like growth factor I/free prostate specific antigen (IGF-I/fPSA) ratio enhances prostate cancer detection in men with total PSA 4.0-10.0 ng/ml.
    Zhigang Z, Jieming L, Su L, Wenlu S.
    J Surg Oncol; 2007 Jul 01; 96(1):54-61. PubMed ID: 17345593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.